Validation of cDNA Microarray Analysis to Distinguish Tumor Type Ex Vivo

Clinical Orthopaedics and Related Research

Volumn 415, Issue SUPPL., 2003, Pages

  Randall, R Lor ^a   Wade, Mark ^b   Albritton, Karen H ^b   Coffin, Cheryl M ^b   Joyner, David E ^b  

^a UNIVERSITY OF UTAH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA;

ANALYSIS OF VARIANCE; BONE METASTASIS; CANCER DIAGNOSIS; CONFERENCE PAPER; DNA MICROARRAY; FIBROMATOSIS; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MESENCHYMOMA; NERVE SHEATH TUMOR; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; REPRODUCIBILITY; TECHNIQUE; TUMOR CLASSIFICATION; VALIDATION PROCESS;

EID: 0142157079     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo0000093060.96273.db     Document Type: Conference Paper

References (56)

1. Afshari CA, Nuwaysir EF, Barrett JC: Application of complementary DNA microarray technology to carcinogen identification, toxicology and drug safety evaluation. Cancer Res 59:4759-4760, 1999.
2. Allander SV, Nupponen NN, Ringner M, et al: Gastrointestinal stromal tumors with KIT mutations exhibit a remarkably homogeneous gene expression profile. Cancer Res 61:8624-8628, 2001.
3. Angus-Hill ML, Schlichter A, Roberts D, et al: A Rsc3/Rsc30 zinc cluster dimer reveals novel roles for the chromatin remodeler RSC in gene expression and cell cycle control. Mol Cell 7:741-751, 2001.
4. Bennicelli JL, Barr FG: Genetics and the biologic basis of sarcomas. Curr Opin Oncol 11:267-274, 1999.
5. Bitran JD, Ultmann JE: Malignancies of undetermined primary origin. Dis Mon 38:213-260, 1992.
6. Bittner M, Meltzer P, Chen Y, et al: Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406:536-540, 2000.
7. Chakrabarti R, Robles LD, Gibson J, et al: Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines. Cancer Genet Cytogenet 139:115-125, 2002.
8. Coleman RE: Skeletal complications of malignancy. Cancer 80:15888-15894, 1997.
9. DeRisi J, Penland L, Brown PO, et al: Use of cDNA microarray to analyze gene expression patterns in human cancer. Nat Genet 14:457-460, 1996.
10. DeVos J, Thykjaer T, Tarte K, et al: Comparison of gene expression profiling between malignant and normal plasma cells with oligonucletide arrays. Oncogene 21:6848-6857, 2002.
11. Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863-14868, 1998.
12. Evtimova V, Schwirzke M, Tarbe N, et al: Identification of breast cancer metastasis-associated genes by chip technology. AntiCancer Res 21:3799-3806, 2001.
13. Florell SR, Coffin CM, Holden JA, et al: Preservation of RNA for functional genomic studies: A multidisciplinary tumor bank protocol. Mod Pathol 14: 116-128, 2001.
14. Fu Z, Dozmorov IM, Keller ET: Osteoblasts produce soluble factors that induce a gene expression pattern in non-metastatic prostate cancer cells, similar to that found in bone metastatic prostate cancer cells. Prostate 15:10-20, 2002.
15. Golub TR, Slonim DK, Tamayo P, et al: Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 286:531-537, 1999.
16. Greenberg SA: Bioinformatics in Microarray Expression Analysis Technology. In Warrington JA, Todd R, Wong D (eds). Microarrays and Cancer Research. Westborough, MA, Eaton Publishing 25-42, 2002.
17. Habermann ET, Sachs R, Stem RE: The pathology and treatment of metastatic disease of the femur. Clin Orthop 169:70-82, 1982.
18. Hoffmann R, Seidi T, Dugas M: Profound effect of normalization on detection of differentially expressed genes in oligonucleotide microarray data analysis. Genome Biol 3:7, 2002.
19. Holmes FF, Fouts TL: Metastatic cancer of unknown primary site. Cancer 26:816-820, 1970.
20. Khan J, Simon R, Bittner M, et al: Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res 58:5009-5013, 1998.
21. Khan J, Bittner ML, Saal LH, et al: cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. Proc Natl Acad Sci USA 96:13264-13269, 1999.
22. Krulik M: Metastatic cancers of unknown primary site. Presse Med 25:1754-1758, 1996.
23. Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics, 1998. CA Cancer J Clin 48:6-29, 1998.
24. Lee MT, Kuo FC, Whitmore GA, Sklar J: Importance of replication in microarray gene expression studies: Statistical methods and evidence from repetitive cDNA hybridizations. Proc Natl Acad Sci USA 97:9834-9839, 2000.
25. Lipshutz RJ, Fodor SP, Gingeras TR, Lockhart DJ: High density synthetic oligonucleotide arrays. Nat Genet 21:20-24, 1999.
26. Lleander VC, Goldstein G, Horsley II JS: Chemotherapy in the management of metastatic cancer of unknown primary site. Oncology 26:265-270, 1972.
27. Mayanil CS, George D, Freilich L, et al: Microarray analysis detects novel Pax3 downstream target genes. J Biol Chem 276:49299-49309, 2001.
28. Mellick AS, Day CJ, Weinstein SR, et al: Differential gene expression in breast cancer cell lines and stroma-tumor differences in microdissected breast cancer biopsies revealed by display array analysis. Int J Cancer 100:172-180, 2002.
29. Misra J, Schmitt W, Hwang D, et al: Interactive exploration of microarray gene expression patterns in a reduced dimensional space. Genome Res 12: 1112-1120, 2002.
30. Moertel CG, Reitemeier RJ, Schutt AJ, Hahn RG: Treatment of the patient with adenocarcinoma of unknown origin. Cancer 30:1469-1472, 1972.
31. Mousses S, Bubendorf L, Wagner U, et al: Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays. Cancer Res 62:1256-1260, 2002.
32. Nielsen TO, West RB, Linn SC, et al: Molecular characterization of soft tissue tumours: A gene expression study. Lancet 359:1301-1307, 2002.
33. Nishizuka I, Ishikawa T, Hamaguchi Y, et al: Analysis of gene expression involved in brain metastasis from breast cancer using cDNA microarray. Breast Cancer 9:26-32, 2002.
34. Nystrom JS, Weiner JM, Wolf RM, Bateman JR, Viola MV: Identifying the primary site in metastatic cancer of unknown origin: Inadequacy of roentgenographic procedures. JAMA 24:381-383, 1979.
35. Olshen AB, Jain AN: Deriving quantitative conclusions from microarray expression data. Bioinformatics 18:961-970, 2002.
36. Pease AC, Solas D, Sullivan EJ, et al: Light-generated oligonucleotide arrays for rapid DNA sequence analysis. Proc Natl Acad Sci USA 91:5022-5026, 1994.
37. Potts JT: Diseases of the Parathyroid Gland and Other Hyper- and Hypocalcemic Disorders. In Isselbacher KJ, Braunwald E, Wilson JD, et al (eds). Harrison's Principles of Internal Medicine. Ed 13. New York, McGraw-Hill 2151-2217, 1994.
38. Raetz EA, Moos PJ, Szabo A, Carroll WL: Gene expression profiling: Methods and clinical applications in oncology. Hematol Oncol Clin North Am 15:911-930, 2001.
39. Ramoni MF, Sebastiani P, Krobane IS: Cluster analysis of gene expression dynamics. Proc Natl Acad Sci USA 99:9121-9126, 2002.
40. Randall RL, Wade M, Albritton KH, Joyner D: Retrieval yield of total and messenger RNA in mesenchymal tissue. Clin Orthop, in press.
41. Ree AH, Engebraaten O, Hovig E, Fodstad O: Differential display analysis of breast carcinoma cells enriched by immunomagnetic target cell selection: Gene expression profiles in bone marrow target cells. Int J Cancer 97:28-33, 2002.
42. Rho J, Altmann CR, Socci ND, et al: Gene expression profiling of osteoclast differentiation by combined suppression subtractive hybridization (SSH) and cDNA microarray analysis. DNA Cell Biol 21: 541-549, 2002.
43. Rougraff BT, Kneisl JS, Simon MA: Skeletal metastases of unknown origin: A prospective study of a diagnostic strategy. J Bone Joint Surg 75A: 1276-1281, 1993.
44. Saito-Hisaminato A, Katagiri T, Kakiuchi S, et al: Genome-wide profiling of gene expression in 29 normal human tissues with cDNA microarray. DNA Res 9:35-45, 2002.
45. Shmulevich I, Hunt K, El-Naggar A, et al: Tumor specific gene expression profiles in human leiomyosarcoma: An evaluation of intratumor heterogeneity. Cancer 94:2069-2075, 2002.
46. Soderstrom M, Bohling T, Ekfors T, et al: Molecular profiling of human chondrosarcomas for matrix production and cancer markers. Int J Cancer 100:144-151, 2002.
47. Sterrenburg E, Turk R, Boer JM, van Ommen GB, den Dunnen JT: A common reference for cDNA microarray hybridizations. Nucleic Acids Res 30: e116, 2002.
48. Stewart JF, Tattersall MH, Woods RL, Fox RM: Unknown primary adenocarcinoma: incidence of overinvestigation and natural history. Br Med J 1: 1530-1533, 1979.
49. Swanson KC, Pritchard DJ, Sim FH: Surgical treatment of metastatic disease of the femur. J Am Acad Orthop Surg 8:56-65, 2000.
50. Wang W, Wyckoff JB, Frohlich VC, et al: Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling. Cancer Res 62:6278-6288, 2002.
51. Wolf M, El-Rifai W, Tarkkanen M, et al: Novel findings in gene expression detected in human osteosarcoma by cDNA microarray. Cancer Genet Cytogenet 123:128-132, 2000.
52. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, IARC Press 2002.
53. Yoo J, Robinson RA: H-ras and K-ras mutations in soft tissue sarcoma: Comparative studies of sarcomas from Korean and American patients. Cancer 86: 58-63, 1999.
54. Zhou H, Randall RL, Brothman AR, et al: Her-2/neu staining in osteosarcoma: association with increased risk of metastasis and can be associated with gene amplification. J Pediatr Hematol Oncol 25:27-32, 2003.
55. Zhu SX, Lee JC, Lashkari D, et al: Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci USA 96:9212-9217, 1999.
56. Zweiger G: Knowledge discovery in gene-expression-microarray data: Mining the information output of the genome. Trends Biotechnol 17:429-436, 1999.